Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant‐like effects of ketamine

The emerging antidepressant effects of ketamine have inspired tremendous interest in its underlying neurobiological mechanisms, although the involvement of 5‐HT in the antidepressant effects of ketamine remains unclear.

• Publication year

  2024

• Venue

  British Journal of Pharmacology

• Publication date

  2024-09-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/bph.17324PMID 39238235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A systematic review of studies investigating the acute effects of N-methyl- D -aspartate receptor antagonists on behavioural despair in normal animals suggests poor predictive validity

  2022cited by this paper
• Planning experiments: Updated guidance on experimental design and analysis and their reporting III

  2022cited by this paper
• Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain

  2022cited by this paper
• Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice

  2022cited by this paper
• A genetically encoded sensor for measuring serotonin dynamics

  2021influential reference
• Sustained effects of rapidly-acting antidepressants require BDNF-dependent MeCP2 phosphorylation

  2021cited by this paper
• The Role of the Excitation:Inhibition Functional Balance in the mPFC in the Onset of Antidepressants.

  2021cited by this paper
• The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects

  2021cited by this paper
• Ketamine triggers rapid antidepressant effects by modulating synaptic plasticity in a new depressive-like mouse model based on astrocyte glutamate transporter GLT-1 knockdown in infralimbic cortex.

  2021cited by this paper
• Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.

  2021cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

  2021cited by this paper
• ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

  2020cited by this paper
• Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses

  2020cited by this paper
• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*

  2020cited by this paper
• Reward Inhibits Paraventricular CRH Neurons to Relieve Stress.

  2019cited by this paper
• (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism

  2019cited by this paper
• Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.

  2019cited by this paper
• Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

  2018cited by this paper
• Ketamine and Other Glutamate Receptor Modulators for Depression in Bipolar Disorder in Adults

  2017cited by this paper
• Effects of the chronic restraint stress induced depression on reward‐related learning in rats

  2017cited by this paper
• The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine

  2017cited by this paper
• 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model

  2017cited by this paper
• Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression

  2017cited by this paper
• Parachlorophenylalanine‐induced 5‐HT depletion alters behavioral and brain neurotransmitters levels in 6‐Hz psychomotor seizure model in mice

  2017cited by this paper
• Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant‐like activity in BALB/cJ mice

  2017cited by this paper
• Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test.

  2015cited by this paper
• Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

  2015cited by this paper
• The forced swim test as a model of depressive-like behavior.

  2015cited by this paper
• Changes in serotonin (5-HT) and brain-derived neurotrophic factor (BDFN) expression in frontal cortex and hippocampus of aged rat treated with high tryptophan diet.

  2015cited by this paper
• Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

  2015cited by this paper
• Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex.

  2014cited by this paper
• Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism

  2013cited by this paper
• Impacts of Brain Serotonin Deficiency following Tph2 Inactivation on Development and Raphe Neuron Serotonergic Specification

  2012cited by this paper
• A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challenge

  2012cited by this paper
• Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex.

  2012cited by this paper
• Ketamine as a Novel Antidepressant: From Synapse to Behavior

  2012cited by this paper
• Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.

  2012cited by this paper
• Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

  2011cited by this paper
• A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.

  2010cited by this paper
• Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

  2010cited by this paper
• Brain-specific conditional and time-specific inducible Tph2 knockout mice possess normal serotonergic gene expression in the absence of serotonin during adult life.

  2010cited by this paper
• The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments

  2010cited by this paper
• Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice.

  2009cited by this paper
• Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.

  2008cited by this paper
• AMPA and NMDA receptor regulation of firing activity in 5‐HT neurons of the dorsal and median raphe nuclei

  2007cited by this paper
• The serotonergic system and anxiety

  2007cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Ketamine Produces Lasting Disruptions in Encoding of Sensory Stimuli

  2006cited by this paper
• The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

  2005cited by this paper
• Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices.

  2004influential reference
• The effects of chronic antidepressant treatment in an animal model of anxiety

  2004cited by this paper
• 5,7‐DHT‐induced hippocampal 5‐HT depletion attenuates behavioural deficits produced by 192 IgG‐saporin lesions of septal cholinergic neurons in the rat

  2002influential reference
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.

  1985cited by this paper

• Ketamine treatment alleviates suicide ideation in high-risk populations: a systematic review and meta-analysis

  2026cites this paper
• The role of probiotics in modulation of the gut-brain axis: a prospective therapy for depression and mood disorders

  2026cites this paper
• Endoplasmic Reticulum Stress in the Keratinocytes Contributes to Chronic Itch by Activation of Lipocalin 2/MC4R/TRPV1 Pathway.

  2026cites this paper
• NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity

  2025cites this paper
• Ascorbic acid enhances antidepressant-like efficacy of esketamine: Hippocampal TARP-γ8-containing AMPA receptors mediate synaptic modulation.

  2025cites this paper
• Optical and electrochemical probes-assisted dual-mode nanosensor for ultrasensitive monitoring of serotonin in single cells.

  2025cites this paper
• Scopolamine exerted antidepressant-like behavioral effects via restoring the synaptic plasticity in CRS-treated mice

  2025influential citation
• ECHINATIN AS A MULTIMODAL MODULATOR OF MONOAMINERGIC SYSTEM: PRECLINICAL EVIDENCE FOR ANTIDEPRESSANT-LIKE ACTIVITY.

  2025cites this paper
• Antidepressant-like actions of lanifibranor and its related mechanisms in mouse models of depression: Involvement of hippocampal PPARα and BDNF.

  2025cites this paper
• From orphan receptor to inflammation regulation: The role of GPR35 in the pathogenesis of depression.

  2025cites this paper